Will Date
Learn from other fields to enhance your practice, vascular surgeon innovators...
“A lot of solutions to your problems exist in somebody else's operating room, or somebody else's cath lab, but you never actually go there.”...
First-in-man results to show promise for robot-assisted HIFU in PAD treatment
Results of a first-in-human study of non-invasive, robotic-assisted high intensity focused ultrasound (HIFU) for the treatment of peripheral arterial disease (PAD), to be presented...
What the cost of cancer care teaches vascular specialists
How does the cost of treating critical limb-threatening ischemia (CLTI) in the U.S. stack up to cancer care? That was the question at the...
CX 2025: Sirolimus implant fails to meet fistula maturation endpoint in...
Results of the ACCESS 2 study, evaluating arteriovenous fistula (AVF) outcomes following use of the Sirogen (Vascular Therapies) sirolimus-eluting collagen implant, have shown that...
ACC.25: Semaglutide improves walk distance for PAD patients with diabetes
Semaglutide significantly improved maximal walking distance in people with symptomatic peripheral arterial disease (PAD) and type 2 diabetes in a trial designed to evaluate...
One-year WAVE trial results show patency advantage for Wrapsody versus PTA
Merit Medical Systems has announced that the six-month results from the randomized arm of the Wrapsody arteriovenous access efficacy—WAVE—trial are scheduled for publication in...
Stereotaxis seeks to broaden use of its robotic magnetic navigation system...
Stereotaxis has announced a Food and Drug Administration (FDA) regulatory submission for the first robotically navigated catheter designed to expand usage of robotic magnetic...
Gore receives CE mark for lower profile Viabahn VBX endoprosthesis
Gore has announced recent CE mark of a lower profile Viabahn VBX balloon expandable endoprosthesis (VBX stent graft).
Medical Device Regulation (MDR) approval of this...